Remote learning for medical student-level dermatology during the COVID-19 pandemic - 09/11/20
Funding sources: None. |
|
Conflicts of interest: Dr Levitt has served on advisory boards for Janssen Biotech, Inc, Novartis, UCB, Biofrontera, Menlo Therapeutics, LEO Pharma, and Arcutis Biotherapeutics and has been a consultant for Novartis, AbbVie Inc, Medscape, and the Corona Psoriasis Registry. Authors Patel, Tsui, and Varma declare no conflict of interests. |
|
IRB approval status: Exempt. |
|
Reprints not available from the authors. |
Vol 83 - N° 6
P. e469-e470 - décembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.